Ceapro Inc (CRPOF) 0.2072 $CRPOF Ceapro to Present on

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ceapro Inc (CRPOF) 0.2072 $CRPOF

Ceapro to Present on Pressurized Gas Expanded Technology (PGX) at the 12th Annual BIO World Congress on Industrial Biotechnology
Marketwired - Thu Jul 09, 7:05AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company", a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that an abstract on its novel Pressurized Gas eXpanded (PGX) platform processing technology will be presented at the 12th Annual BIO World Congress on Industrial Biotechnology being held July 19-22, 2015, at the Montreal Convention Center, in Montreal, Canada.
CZO.VN: 0.250 (unch)

Ceapro Featured at the 12th International Congress on Engineering and Food (ICEF12)
Marketwired - Mon Jun 15, 7:02AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company", a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced its featured participation in the 12th International Congress on Engineering and Food (ICEF12) being held June 14-18, 2015, at the Quebec City Convention Centre in Quebec City, Canada.
CZO.VN: 0.250 (unch)

Ceapro Announces Election of Directors at 2015 Shareholders' Meeting
Marketwired - Tue Jun 09, 7:03AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company", a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that all proposed Directors, Mr. Gilles Gagnon, Dr. Ulrich Kosciessa, Dr. William W. Li, Mr. Don Oborowsky, Mr. Glenn R. Rourke and Mr. John Zupancic, were elected to serve for a one-year term at its annual meeting of shareholders held on June 3, 2015.
CZO.VN: 0.250 (unch)

Ceapro Inc. Reports First Quarter 2015 Financial and Operations Results
Marketwired - Mon Jun 01, 8:02AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company", a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today its financial results for the three-months ended March 31, 2015 and provided an overview of recent operational highlights.
CZO.VN: 0.250 (unch)

Ceapro to Develop Enabling Pressurized Gas Expanded Technology (PGX) at Commercial and Demonstration Scale
Marketwired - Thu May 28, 6:05AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company", a growth-stage biotechnology company focused on the development and commercialization of active ingredients for the healthcare and cosmetic industries, announced today it will embark on a scale-up of its proprietary PGX technology to commercial and demonstration levels.
CZO.VN: 0.250 (unch)

Ceapro Announces Appointment of New Chief Financial Officer
Marketwired - Tue May 05, 6:06AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company", a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today it has appointed Stacy Prefontaine, CA, as Chief Financial Officer. Ms. Prefontaine replaces Branko Jankovic who is leaving his position effective immediately.
CZO.VN: 0.250 (unch)

Ceapro Appoints Seasoned Pharmaceutical Industry Executive, Ulrich Kosciessa, Ph.D., to its Board of Directors
Marketwired - Tue Apr 28, 7:03AM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company", a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today it has appointed international pharmaceutical industry expert, Ulrich Kosciessa, Ph.D., to its Board of Directors.
CZO.VN: 0.250 (unch)

Ceapro Reports Record Full-Year 2014 Financial Results
Marketwired - Wed Apr 22, 7:02AM CDT
Ceapro Inc. (TSX VENTURE: CZO) (Ceapro or the Company), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today its financial results for the twelve-months ended December 31, 2014 and provided an overview of recent operational highlights and expected business milestones for 2015.
CZO.VN: 0.250 (unch)

Ceapro Expands License Agreement With University of Alberta for PGX Technology
Marketwired - Wed Feb 11, 7:03AM CST
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company", a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced an expansion to its agreement with the University of Alberta for the development and commercialization of an innovative drying technology called Pressurized Gas eXpanded Technology (PGX) to include all fields of use, including emerging industrial opportunities. The original agreement was established in April 2014 for the development and commercialization of the PGX technology in select large markets like cosmeceuticals, functional food, nutraceuticals and pharmaceuticals.
CZO.VN: 0.250 (unch)

Ceapro Raises an Additional $310,000 Through a Non-Brokered Private Placement
Marketwired - Wed Feb 04, 4:01PM CST
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company", a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that it has closed a $310,000 second tranche of its previously announced private placement of eight (8) percent unsecured convertible debentures (the "Debentures" due December 31, 2016, with interest payable on June 30 and December 31 of each year.
CZO.VN: 0.250 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PolyBio Convergence Summit Tackles Aging, Chronic Illness

Updated Category News Views 146

Kicking Off The Convergence: Pathogens in Focus Here's a gathering that's set to challenge how we think about lingering illnesses and aging. PolyBio Research Foundation is bringing a powerhouse of brains to the table with their inaugural Convergence Summit. It's more than just science talk; it's a chance to push boundaries in understanding how pathogens stick around and...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 69

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 142

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 155

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
equipifi's BNPL Shop: New Ammo for Credit Unions

Updated Category News Views 87

equipifi's 'Shop': The Big Play in Banking Look, here’s the deal—equipifi just lobbed a new grenade into the finance battlefield, arming credit unions and community banks with 'Shop', their own Buy Now, Pay Later (BNPL) platform. The goal? To put them toe-to-toe with the big fintech wolves—something these smaller guys desperately needed. It's a meaty move, no...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 71

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Thread AI Joins Microsoft Pegasus: Big AI Leap

Updated Category News Views 26

Thread AI Leaps Ahead with Microsoft Partnership There's excitement in the air as Thread AI joins forces with Microsoft by entering the exclusive Pegasus Program. In the ever-evolving world of AI, making a splash this big doesn't happen every day. People in the tech alley are buzzing, and it looks like Thread AI is ready to rumble on a larger stage—much like a scrappy...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 85

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 67

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 135

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading

Top 5 Most Recently Viewed Articles

Conagra Brands: Navigating Challenges with Strong Dividends and Growth

Updated Category News Views 164

Conagra's Market Position and Opportunities Conagra Brands Inc (NYSE: CAG) shares are currently experiencing a significant dip, providing a favorable opportunity for long-term investors to consider entry into the market. Despite the ongoing challenges that are affecting the consumer staples sector, Conagra has ended its recent business contraction. The company's...

Continue Reading
Unlocking the Potential of AeroVironment Stock Investments

Updated Category News Views 215

The Growth Journey of AeroVironment (NASDAQ: AVAV) AeroVironment continues to impress investors with its steady performance over recent years. This aerospace company specializes in drone technology and has showcased remarkable growth potential in a competitive industry. Despite the challenges posed by changing market conditions, AeroVironment has outperformed the market...

Continue Reading
Focal One® Robotic HIFU Shows Promise in Prostate Cancer Care

Updated Category News Views 131

Groundbreaking Results from the HIFI Study The HIFI Study stands as a significant milestone in the treatment of localized prostate cancer, presenting remarkable findings and setting the stage for a shift in medical practices. This extensive research, with a participant group of 3,328, compares HIFU treatment using Focal One® against traditional surgery methods,...

Continue Reading
VENU's Ambitious Growth Strategy Secures $34.5 Million Funding

Updated Category News Views 307

VENU Secures Funding to Propel Its Growth Strategy In recent news, VENU (NYSE American: VENU), a company leading the charge in premium hospitality and live entertainment, has successfully closed a public offering. This offering involved 2,875,000 shares of common stock, sold at a public price of $12.00 each, bringing in $34.5 million in gross proceeds. This substantial...

Continue Reading
Exploring Market Trends in the Food Colors Industry

Updated Category News Views 250

The food colors market saw a hefty rise, hitting projections of USD 6.0 billion by 2028 from USD 4.6 billion in 2023. This growth came at a compound annual growth rate (CAGR) of about 5.4%, thanks to shifting consumer preferences towards naturally sourced and visually appealing products. Market Dynamics: The Push for Natural Colors Back then, the processed food scene was...

Continue Reading